Capital Fund Management (CFM)
SNDX icon

Capital Fund Management (CFM)’s Syndax Pharmaceuticals SNDX Stock Holding History

Capital Fund Management (CFM)’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.73M Sell
125,091
-20,475
-14% -$426K 0.01% 1243
2026
Q1 		$3.4M Sell
145,566
-88,305
-38% -$1.92M 0.02% 1094
2025
Q4 		$4.91M Sell
233,871
-107,323
-31% -$1.87M 0.01% 1203
2025
Q3 		$5.25M Buy
341,194
+162,905
+91% +$2.13M 0.01% 1218
2025
Q2 		$1.67M Buy
+178,289
New +$1.96M ﹤0.01% 1770

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Capital Fund Management (CFM)'s SNDX Position: Q2 2026 in Review

Capital Fund Management (CFM) reduced its Syndax Pharmaceuticals (SNDX) stake by 14% in Q2 2026, selling an estimated $426K and leaving 125,091 shares worth $2.73M. The position accounts for 0.01% of the portfolio, ranked #1243.

Capital Fund Management (CFM) first reported a position in SNDX in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.25M in Q3 2025. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Capital Fund Management (CFM) held 125,091 shares of Syndax Pharmaceuticals worth $2.73M as of Q2 2026.
  • Capital Fund Management (CFM) sold 20,475 Syndax Pharmaceuticals shares in Q2 2026, an estimated $426K.
  • Syndax Pharmaceuticals made up 0.01% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1243 holding.
  • Capital Fund Management (CFM) first reported a position in Syndax Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Capital Fund Management (CFM)'s Syndax Pharmaceuticals position peaked at $5.25M in Q3 2025.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.